Nussbaum Robert L
- SEC CIK
- 0001640322
No open-market purchases or sales filed in the past year.
Current role at each company
- NVTA Invitae CorpChief Medical Officeras of Dec 21, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Nussbaum Robert L as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2023 (view filing) | Jun 13 | 2 days | Nussbaum Robert LChief Medical Officer | SSale | −7.09K | $1.38 | −$9.78K | −1.2%569.3K after | |
| May 18, 2023 (view filing) | May 16 | 2 days | Nussbaum Robert LChief Medical Officer | SSale | −26.5K | $1.20 | −$31.8K | −4.4%576.4K after | |
| Mar 15, 2023 (view filing) | Mar 13 | 2 days | Nussbaum Robert LChief Medical Officer | SSale | −2.63K | $1.41 | −$3.70K | −0.6%447.9K after | |
| Aug 18, 2022 (view filing) | Aug 16 | 2 days | Nussbaum Robert LChief Medical Officer | SSale | −7.05K | $4.55 | −$32.1K | −1.7%396.5K after | |
| May 19, 2022 (view filing) | May 17 | 2 days | Nussbaum Robert LChief Medical Officer | SSale | −6.10K | $3.81 | −$23.2K | −1.5%403.6K after | |
| Mar 16, 2022 (view filing) | Mar 14 | 2 days | Nussbaum Robert LChief Medical Officer | SSale | −19.6K | $6.69 | −$131.0K | −7.5%241.2K after | |
| Nov 15, 2021 (view filing) | Nov 11 | 4 days | Nussbaum Robert LChief Medical Officer | SSale | −29.7K | $21.89 | −$649.6K | −10.8%246.1K after | |
| Aug 18, 2021 (view filing) | Aug 16 | 2 days | Nussbaum Robert LChief Medical Officer | SSale | −21.2K | $25.42 | −$539.7K | −7.9%246.1K after |